Latest News & Features
Big Pharma
In a victory for Teva Pharmaceuticals, the US Court of Appeals for the Federal Circuit dismissed IBSA Institut Biochimique’s appeal against a ruling that held parts of its patent invalid. 10 August 2020
Americas
In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis. 7 August 2020
Big Pharma
Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application. 6 August 2020
Biotechnology
With any rapidly-developing field, particularly the life sciences, the importance of a coherent IP strategy cannot be ignored. 6 August 2020
Americas
The US Court of Appeals for the Federal Circuit will not revisit its ruling that saved the patent eligibility of two DNA test patents owned by biotechnology company Illumina, after the court rejected an en banc request from a subsidiary of Roche. 6 August 2020
Big Pharma
IP boutique KIPA has strengthened its team with the addition of Iceland-based patent attorney Thorlakur Jonsson. 6 August 2020
Europe
South Korean medical devices manufacturer Medit has prevailed in a patent infringement lawsuit brought by Danish rival 3Shape in Germany. 6 August 2020
article
Pendulum Therapeutics is a pathbreaker company in microbiome therapeutics and gut health. Ypsita Demunshi is a patent agent at Pendulum Therapeutics, where she manages the growing portfolio of patents worldwide and exhibits expertise in life sciences patent prosecution. 5 August 2020
Genetics
The US Court of Appeals for the Federal Circuit has partially lifted an injunction on 10X Genomics, but the biotech company must still pay almost $24 million for infringing a Bio-Rad patent. 4 August 2020
Americas
A former researcher at the research institute of the Nationwide Children’s Hospital in Ohio has pleaded guilty to conspiring to steal scientific trade secrets to sell in China. 3 August 2020